Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Safety Trial of Placental Stem Cells for Diabetic Foot Ulcers
NCT07686094Phase 1Not yet recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Mar 2027
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in diabetic foot ulcer (DFU), sponsored by Wake Forest University Health Sciences. Primary endpoints: Number of Injection Sites Bleeding at 12 months, Number of Injection Sites infection/inflammation at 12 months and 4 more. Planned start Mar 2027; status: not yet recruiting.
02
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT07686094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07686094.